Mäkitie and coworkers [27] reported increased immunoreactivity of antizyme inhibitor (AZIN) in the hippocampus of AD patients, which may explain the increased ODC activity found in the brain of AD patients [11]. Here, ODC1 is linked to Alzheimer disease.